Developed by this spin-off from RIDC CDMF, the N95-type respirator is made of material containing silica-silver microparticles with antimicrobial and antifungal properties that hinder surface adhesion by SARS-CoV-2.
Research groups who previously developed low-cost rapid tests for Zika fever and other viral diseases - the CDMF-devised electrochemical sensor with ZnO nanoparticles being one of them - are adapting these models for use in detecting SARS-CoV-2.
Scientists affiliated with the FAPESP-funded Center for Cell-Based Therapy have collected plasma from donors and are conducting a trial to check the safety and effectiveness of passive immunization.
Selected projects aim to repurpose existing drugs for treatment of COVID-19, find novel compounds with therapeutic potential and develop alternative diagnostic methods. The call remains open until June 22.
Amongst all proposals the Scientific Board analyzed by March 31, two were selected, including a study at OCRC that evaluates the effectiveness of drugs that inhibit bradykinin against pulmonary inflammation in critical patients.
Research by CEM shows that it is not feasible to separate high-risk groups in low-income communities, where the majority of the Brazilian population live. The problem is especially acute in the Southeast region, with metropolitan São Paulo displaying the largest deficit.
Patients with chronic diseases display increased expression of gene that facilitates SARS-CoV-2 infection
Metabolic changes associated with diseases such as pulmonary hypertension and chronic obstructive pulmonary disease may reprogram gene expression to increase production of a protein used by SARS-CoV-2 to penetrate lung cells.
Developed in a study featuring participation of RIDC CDMF, the material – zinc-doped manganese chromite – can be used in a range of products, from gas sensors to data storage devices, thanks to its magnetic properties.